Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Mineralfields

<< Previous

Bullboard Posts

Next >>

Comment by Ogre2on Aug 18, 2010 11:30pm

352 Views

Post# 17363834

RE: Mineralfields

But according to your theory, regardless of your emotion dependent upon when you were invested, the price should jump dramatically. You yourself state a 5 cent price. It was obvious flow throughs were pulling it down, now that pressure is off. wrt flow throughs, I floated that theory by the company in one phone call, and it was not shot down.
I would not be surprised if there is some significant announcement tomorrow that would credit the upwards buying pressure.
Cheers,
Ogre

<< Previous

Bullboard Posts

Next >>

Quebecor achieves all Freedom Mobile acquisition commitments